Type I DM Flashcards

1
Q

Insulin therapy is temporarily given when: (6)

A
  1. DM decompensation
  2. Damage to vital organs
  3. Acute myocardial infarction or stroke
  4. Severe hyperglycemia and/or ketonuria, ketoacidosis
  5. Preoperative and postoperative period
  6. Pregnancy or the patient is breastfeeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mechanism of insulin action

A
  • regulate glucose metabolism
  • it has anabolic and catabolic effects in tissues

in muscles –> increases synthesis of glycogen, fatty acids, glycerol, proteins and utilization of amino acids
decrease glycogenolysis, glucogenesis, ketogenesis, lipolysis, protein catabolism and amino acid excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Advantages and Disadvantages of Insulin

A

-insulin lowers glucose in a dose dependent manner over a wide range, to almost any glycemic target as limited by hypoglycemia

Disadvantages

  • risk of hypoglycemia
  • weight gain
  • need for injection
  • titration is needed
  • the effectiveness is dependent on appropriate use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of insulin (4)

A
  • human insulin
  • DNA-derived human insulin
  • Biosynthesis human insulins (short and intermediate acting)
  • insulin analogues - rapid, long and mixed acting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Biosynthetic human insulin

A

Humulin R - short acting, provides insulin substitution for food eaten after 30-60min, subcutaneous use, 30-45 minutes before eating

Humulin N - intermediate acting, provides insulin replacement for about half a day or overnight, subcutaneous use, often combined with short or rapid acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rapid acting insulin analogues (6)

A
  • administered at mealtime - just before or immediately after
  • intensify basal insulin therapy
  • lower risk for hypoglycemia
  • higher cost
  • subcutaneous infusion pump
  • IV is possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ultra fast-acting insulin (2)

A
  • injection should be done 2min before the meal

- might be injected when not more than 20min past from the beginning of eating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Basal insulin (long-acting) (5)

A
  • forms the basis of treatment for both type I and 2 DM
  • effect without peaks, for 24h or longer duration of time
  • provides insulin replacement for about 1 day
  • stabilizes after 2-3 days of daily administration
  • injection once or twice daily subcutaneously
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mixed (biphasic) insulin analogues (5)

A
  • contain fast acting and basal insulin
  • provide both post-prandial and basal insulin requirements
  • available at different concentrations 25/75, 30/70, 50/50
  • first figure = percentage of fast acting insulin, second figure = percentage of basal insulin
  • injection before meal, iv is not allowed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment of 1 TDM (4)

A
  • long-acting (basal bolus regimen) and fast-acting insulin or continuous insulin infusion using insulin pumps
  • bolus dose is selected according to the amount of carbs during a particular meal
  • long acting insulin is usually injected in the evening
  • morning dose is adjusted according to glycemia in the evening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment of 1 TDM

-insulin pump therapy (2)

A
  • fast acting insulin

- either aspart or lispro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of 1 TDM

-how to reduce the risk of hypoglycemia?

A

-fast acting insulin should be used with long-acting insulins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Basal insulin vs Bolus or Prandial insulin

A

Basal insulin

  • long acting insulin
  • goal: cover the body’s basal metabolic insulin requirement (regulates hepatic glucose production)
  • lower risk of hypoglycemia but cost more.

Bolus or Prandial insulin

  • reduce glycemic excursions after meals
  • long + rapid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Patients who are unable to maintain glycemic targets on basal insulin in combination with oral medications can have treatment intensified with….

A

-GLP-1 RA, SGLT-2 inhibitors or Prandial insulin

  • intensified insulin regimens also help, include:
    1. one or more daily injections of rapid or short-acting insulin before meals
    2. switching to one to 3 daily administrations of a fixed combination of short and long acting insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

500 rule

A
  • to calculate carbohydrate to insulin ratio

- 500 divided by the daily dose of insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

100 rule

A
  • to determine the sensitivity for insulin

- 100 divided by the daily dose of insulin

17
Q

1700 rule

A
  • to estimate the correction dose
  • the expected drop in glucose in response to 1 unit of insulin
  • 1700.TDD
18
Q

Injection of insulin recommendations (3)

A
  • change insulin injection site (snake principle)
  • injection into the upper arms is allowed only with 4mm needles
  • replace the needle every 3 days
19
Q

HbA1c

A
  • glycated hemoglobin
  • identifies the average plasma glucose concentration
  • the higher the HbA1c –> the lower the risk of hypoglycemia –> the greater the risk of developing complications
  • provides a long term average –> different than blood glucose level

Prediabetes - 5.7-6.4% (39-47 mmol.mol)
Diabetes - 6.5% or higher (48 mmol/mol)

20
Q

Type I DM

  • pathophysiology
  • symptoms
A
  • autoimmune pancreatic beta cells destruction
  • longer term hyperglycemia –> vascular complication
  • up to 90% of patients will have autoantibodies against at least one of 3 antigens: glutamic acid decarboxylase (GAD), insulin, islet autoAg (IA-2)

-polydipsia, polyuria, polyphagia, weight loss, fatigue, weakness, blurred vision

-

21
Q

Glycemic targets for almost all non-pregnant patients with DM

A

HbA1c –> <7.0%

22
Q
Diabetic ketoacidosis (DKA) 
-pathophysiology
A
  1. stress
  2. epinephrine
  3. glucagon
  4. increase blood glucose
  5. loss of glucose in urine
  6. loss of water
  7. dehydration
  8. ketone bodies
  9. ketoacidosis

no insulin –> potassium outside the cells –> hyperkalemia

23
Q
Diabetic ketoacidosis (DKA) 
-Signs and symptoms (4)
A
  • Fruity breath - acetone
  • Kussmall respiration - deep/labored breathing –> to reduce CO2 levels
  • nausea, vomiting
  • mental status changes, acute cerebral edema
24
Q
Diabetic ketoacidosis (DKA) 
-treatment (4)
A
  • fluid replacement
  • IV insulin –> faster action
  • electrolytes –> K+, Mg2+, Na+, phosphate, bicarbonate (when pH is lower than 6.9)
  • cardiac monitoring, antibiotics for suspected infections
25
Q

Is it possible for DKA to happen in DM type II patients?

A

Yes, because the disease can remain undiagnosed for a long time

26
Q

Which long-acting insulin have the lowest risk of hypoglycemia?

A

Degludec and Glargine

27
Q

Which long-acting insulin have the highest risk of hypoglycemia?

A

NPH insulin